It is now recognized that p27-mediated inhibition of cyclin-dependent kinase 2 represses mTOR in cardiomyocytes [8], that p27 can function as an anti-hypertrophic factor, and that p27 is down-regulated during heart failure and cardiac hypertrophy [36]. This evidence concerns the gene MTOR and cardiac hypertrophy.